Dr. Ian Schnadig

Dr. Ian Schnadig, MD, is a highly respected medical oncologist recognized for his expertise in gastrointestinal cancers, lung cancers, and hematologic malignancies. He serves as a senior medical oncologist at Compass Oncology, part of the US Oncology Network, where he is deeply involved in both patient care and clinical research. Dr. Schnadig earned his medical degree from Rush Medical College in Chicago, Illinois, and completed his residency in internal medicine at the University of California, Irvine. He went on to complete fellowship training in hematology and oncology at the University of California, San Francisco, where he developed a strong focus on integrating cutting-edge science into community-based cancer care. He is board-certified in Internal Medicine, Hematology, and Medical Oncology.

A leader in advancing oncology care in community settings, Dr. Schnadig has served as principal investigator on numerous clinical trials spanning targeted therapy, immunotherapy, and supportive care interventions. His research interests include genomic profiling, treatment sequencing in advanced cancers, and improving quality-of-life outcomes through personalized treatment approaches. He has authored and co-authored peer-reviewed publications and has been a frequent presenter at national oncology conferences, contributing to the dissemination of new treatment paradigms.

In addition to his clinical and research work, Dr. Schnadig is a strong advocate for patient-centered care and has been recognized for his compassionate approach to medicine. He actively mentors younger physicians and oncology fellows, emphasizing the importance of combining clinical excellence with empathy. Through his leadership in clinical research and commitment to bridging academic innovation with real-world practice, Dr. Ian Schnadig continues to enhance cancer treatment accessibility and quality across diverse patient populations.